More
    Guided Solutions - Connecting Talent With Innovation/div>

    Beacon Biosignals upsizes Series B to $97M

    Funding
    Beacon Biosignals announced that it extended its Series B financing to bring the round to $97 million. In November 2025, the Boston-based company announced that it raised $86 million in its oversubscribed Series B round....

    Beacon Biosignals upsizes Series B to $97M

    Funding
    Beacon Biosignals announced that it extended its Series B financing to bring the round to $97 million. In November 2025, the Boston-based company announced that...

    neuroClues closes €10M Series A, bringing total funding to €25M

    Funding
    neuroClues, a MedTech company developing objective, quantitative tools for neurological assessment, announced the close of a €10 million Series A financing round. The investment brings...

    FDA grants 510(k) clearance for Allevion Medical’s Vantage system

    Regulatory Approvals
    Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...

    Lifebloom secures €8M for exoskeleton walking therapy

    Funding
    French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

    Get Weekly Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Innovation

    Regulatory Approvals

    Beacon Biosignals upsizes Series B to $97M

    Beacon Biosignals announced that it extended its Series B financing to bring the round to $97 million. In November 2025, the Boston-based company announced that...

    neuroClues closes €10M Series A, bringing total funding to €25M

    neuroClues, a MedTech company developing objective, quantitative tools for neurological assessment, announced the close of a €10 million Series A financing round. The investment brings...

    FDA grants 510(k) clearance for Allevion Medical’s Vantage system

    Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...

    Lifebloom secures €8M for exoskeleton walking therapy

    French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

    M&A

    Archives

    Latest articles

    Load more

    Popular categories

    Funding1110Regulatory Approvals1001Innovation651Clinical Trials514Mergers & Acquisitions497

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices